Peculiarities of lipid and protein peroxidation in autoimmune thyroiditis with and without mild thyroid dysfunction

The aim of this study was to investigate lipid and protein peroxidation in autoimmune thyroiditis (AT) and subclinical hypothyroidism (SH), as well as to evaluate its correlation for arterial stiffness and relationship to replacement treatment. Methods. The study included 85 women; 32 of them had no thyroid pathology (group 1, controls) and 53 had AT and SH (group 2). Free-radical protein and lipid oxidation (FRO), serum antioxidant activity (AOA), arterial elasticity parameters were investigated. In addition, we compared different categories of the patients included in group 2: patients having euthyroidism ( n = 18) and subclinical hypothyroidism ( n = 35); AT patients with TSH less ( n = 26)and not less ( n = 27) than the median of group values (∼ 6 mU/ml). In 33 patients the dynamic changes of FRO were reevaluated after 6–8 months of thyroxine replacement. Results. AT patients demonstrated higher oxidative protein modification rate (OMB) which was confirmed by 75% elevation of OMB 363nm index ( p = 0,049) and greater activity of lipid peroxidation (LPO) confirmed by 11% elevation of luminescence intensity index Imax ( p = 0,035) but no increase in AOA, catalase and superoxide dismutase activity ( p > 0,05). Oxidative stress severity was positively associated with TSH; dyslipidaemia had a stronger influence on oxidative stress. The proportions of women with relative disparity between elevated malondialdehyde (MDA) and depressed antioxidant activity (AOA), were significantly higher in AT and SH groups ( р < 0,05). The most significant difference between oxidative stress parameters was found among patients having TSH less and not less then 6 mU/ml. The subgroup with higher TSH was found to have higher indexes of endogenous intoxication and LPO products values (the increase of EI254nm, EI274nm, EI294nm, triene conjugates by 18%; 19%; 29% и 38% respectively, p <0,05). Oxidative stress can affect arterial stiffness and vascular remodeling. Levothyroxine activates pro- and antioxidants but antioxidants are more significantly involved, and balance can be improved. Conclusion. AT is accompanied by FRO activation, АОА depression, their imbalance and oxidative stress development. Significant correlations are observed for TSH, dislipidaemia and FRO. Oxidative stress demonstrates detrimental effects on arterial functions which may be partly reversed by replacement therapy. Levothyroxine activates pro- and antioxidants with the predominant positive effect on AOA.

lipid and protein peroxidation, subclinical hypothyroidism, arterial stiffness, replacement treatment

1. Фадеев В.В. Заболевания щитовидной железы в регионе легкого йодного дефицита: эпидемиология, диагностика, лечение. М.: Видар, 2005. 24–25.

2. Сыч Ю.П., Калашникова В.Ю. и др. Нарушения функционального состояния сердечно-сосудистой системы при субклиническом гипотиреозе. Клин. мед. 2003; 11: 4–9.

3. Аметов А.С., Белоножкина Е.С., Павлюченко И.И., Басов А.А. Про- и антиоксидантная система у больных гипотиреозом и ее изменения под влиянием препаратов липоевой кислоты. Пробл. эндокринол. 2007; 2: 49–54.

4. Рогалева А.В., Уразова О.И., Кравец Е.Б. и др. Активность свободнорадикального окисления и антиоксидантной системы в лимфоцитах периферической крови у больных аутоиммунным тиреоидитом. Вестн. РАМН 2010; 3:11–15.

5. Nanda N., Bobby Z., Hamide A. Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin. Exp. Med. 2008; 8 (2):101–108.

6. Sahoo D.K., Roy A., Bhanja S., Chainy G.B. Hypothyroidism impairs antioxidant defence system and testicular physiology dur- ing development and maturation. Gen. Comp. Endocrinol. 2008;

7. (1): 63–70.

8. Baskol G., Atmaca H., Tanriverdi F. et al. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp. Clin. Endocrinol. Diabetes 2007;

9. (8): 522–526.

10. Nanda N., Bobby Z., Hamide A. Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin. Chem. Lab. Med. 2008; 46 (5): 674–679.

11. Santi A., Duarte M.M., Moresco R.N. et al. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin. Chem. Lab. Med. 2010; 48 (11): 1635–1639.

12. Nanda N., Bobby Z., Hamide A. et al. Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism. 2007; 56 (10): 1350–1355.

13. Yilmaz S., Ozan S., Benzer F., Canatan H. Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell. Biochem. Funct. 2003; 21 (4): 325–330.

14. Moulakakis K.G., Poulakou M.V., Dosios T. et al. Hypothyroidism and the aorta. evidence of increased oxidative DNA damage to the aorta of hypothyroid rats. In Vivo. 2008; 22 (5): 603–608.

15. Окислительный стресс: Патологические состояния и заболевания / Е.Б. Меньщикова, Н.К. Зенков, В.З. Ланкин, И.А. Бондарь, В.А. Труфакин. Новосибирск: АРТА, 2008.

16. Torun A.N., Kulaksizoglu S., Kulaksizoglu M. et al. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. (Oxf.) 2009; 70 (3): 469–474.

17. Новицкая А.Б., Стронгин Л.Г., Некрасова Т.А., Конторщикова К.Н. Особенности перекисного окисления липидов и гемодинамики у больных с субклиническим гипотиреозом. Клин. тиреоидол. 2004; 2 (4): 27–31.

18. Арутюнян А.В., Дубинина Е.Е., Зыбина Н.Н. Методы оценки свободнорадикального окисления и антиоксидантной системы организма / Методические рекомендации. СПб.: ИКФ Фолиант, 2000.